Elevated pretreatment serum apolipoprotein E level associated with poor prognosis of patients with COVID-19 during the omicron BA.5 and BF.7 wave.

MLA

Gong, Shengping, et al. “Elevated Pretreatment Serum Apolipoprotein E Level Associated with Poor Prognosis of Patients with COVID-19 during the Omicron BA.5 and BF.7 Wave.” Journal of Medical Virology, vol. 96, no. 5, May 2024, p. e29673. EBSCOhost, https://doi.org/10.1002/jmv.29673.

APA

Gong, S., Ma, C., Ma, R., Zhu, T., Ge, X., Xie, R., Tao, Q., Ouyang, G., & Shi, C. (2024). Elevated pretreatment serum apolipoprotein E level associated with poor prognosis of patients with COVID-19 during the omicron BA.5 and BF.7 wave. Journal of Medical Virology, 96(5), e29673. https://doi.org/10.1002/jmv.29673

Chicago

Gong, Shengping, Chao Ma, Ruishuang Ma, Ting Zhu, Xiaoqin Ge, Rongrong Xie, Qingsong Tao, Guifang Ouyang, and Cong Shi. 2024. “Elevated Pretreatment Serum Apolipoprotein E Level Associated with Poor Prognosis of Patients with COVID-19 during the Omicron BA.5 and BF.7 Wave.” Journal of Medical Virology 96 (5): e29673. doi:10.1002/jmv.29673.